Livzon Pharmaceutical repurchases shares on HKEX and SZSE
Livzon Pharmaceutical Group announced it repurchased 145,400 A-shares on the SZSE for approximately RMB 4,996,896, with prices ranging between RMB 34.22 and RMB 34.51 per share. Additionally, the company reported changes in its issued share capital, reflecting ongoing buyback activities. The company’s issued shares total 604,293,313. These repurchases are part of a previously announced buyback mandate, with the company confirming adherence to all relevant regulations and exchange rules. H-shares were repurchased on the HKEX, with a total of 307,052,417 shares. Further details on each H-share repurchase are listed in this announcement.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime